Member Info for a4007035

It ended down because the FTSE was being dragged down i.e. market factors rather than CLIN specific.

The bid is just a rumour at this stage. Not enough clout to really affect the SP.

But it does give an indication of what could be on the horizon for CLIN in the next 1-2 years. People are sniffing around.

The offer can only be good news.

1. If its accepted we'll all make tidy profit (although not be original target of £20)
2. If its not accepted then management obvs think its worth a lot. The market will drive the SP up

https://www.thisismoney.co.uk/money/news/article-8417997/Advent-International-bought-Cobham-eyes-Clinigen.html

Here is the article.

Times has it at 1.3bn

Whilst I think that a bid is unlikely it highlights the approximate value of £1.5bn that a buyer is willing to pay which will be around £11 per share.

I think it massively undervalues the company.

But it does show that the current SP is even more undervalued.

Sp should really be around the 10p mark. And that's being prudent and conservative.

SP has not been valued correctly. Should be a lot higher than it is currently at.

They have an excellent management team with a proven track record in a niche market.

The company is hugely cash generative and could pay off a substantial volume of its debts. However, the strategy is to focus on becoming a market leader and gaining greater market share. Yes, debt may be higher than ideal but once the acquisitions in the last few years consolidate you will see how much of a big player CLIN really is.

In theory it should be relatively resistant to the virus impact. Its difficult to fully say though.

These SP levels are way too low and prudent. I am going to keep topping up daily/weekly to average down.

Its just priced incorrectly. It should be around 100p mark give or take 10%.

The demise has been somewhat unexpected and unjustified. But we are where we are.

Oh definitely. These are market driven factors rather than the performance of CLIN itself.

I have averaged down by buying more. But Ive hit my limit

This is so cheap at the minute.

Waiting until the markets normalise then buying back in.

20% drop today

I prefer to look at their cash flow statement. Remember cash is always king. And they are hugely cash generative. If they carry on at the same rate that i would be happy.

We have to have faith in the management team. They have delivered very good results so far. CLIN has highly cash generative company. They could easily lower the net debt if they should wish to choose to. But the fact that they are seeking further opportunities all of the time tells me that if they did lower the debt they would lose out on the opportunity costs.

They still have a very strong balance sheet. I think it was a knee jerk reaction from the market and we should see this rise steadily again!

By far, the worst share in my portfolio.

Management team are incapable and incompetent.

You can always buy back in. SP isn't going anywhere significant for a while.

£4m of BUYS

Currency exchange losses. Hard to know

Who says they have been downgraded? There is nothing on the net about this.

I'm certain that it is China. In Jan they said they were confident of hitting the upper end of their profit targets - not much can have changed between now and then.

As an accountant, the only thing that I'm worried on is selective accounting where the Exec. only select the numbers and adjustments that paint a positive picture. But to be honest you can't really falsify/elaborate a cashflow statement and they are hugely cash generative which can only be positive.

What they need now is stability and a position of organic growth and consolidation of their recent acquisitions. That should help support lowering the debt profile.

Where is this change of position?

Half year result expected on 25/02/2020.

China will have caused the dip. Surprised it hasnt been more to be honest.